{"version":"1.0","provider_name":"Canadian Digestive Health Foundation","provider_url":"https:\/\/cdhf.ca\/fr\/","author_name":"Sophie Allan","author_url":"https:\/\/cdhf.ca\/fr\/author\/sophie-allen\/","title":"Les Options de traitements pour les MII: comprendre les avantages et les risques - Canadian Digestive Health Foundation","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1z64NfHKkY\"><a href=\"https:\/\/cdhf.ca\/fr\/understanding-the-benefits-and-risks-of-ibd-therapies\/\">Les Options de traitements pour les MII: comprendre les avantages et les risques<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cdhf.ca\/fr\/understanding-the-benefits-and-risks-of-ibd-therapies\/embed\/#?secret=1z64NfHKkY\" width=\"600\" height=\"338\" title=\"&#8220;Les Options de traitements pour les MII: comprendre les avantages et les risques&#8221; &#8212; Canadian Digestive Health Foundation\" data-secret=\"1z64NfHKkY\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cdhf.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/cdhf.ca\/wp-content\/uploads\/2022\/08\/webinar.webp","thumbnail_width":1640,"thumbnail_height":924,"description":"This empowering session reviewed the basics of IBD, outlined the benefits and risks of medications used to treat ulcerative colitis and Crohn\u2019s disease and answered the many questions of attendees.\u00a0Special thanks to Dr. Talat Bessissow for sharing his insights and expertise and to AbbVie Inc. for sponsoring our IBD Treatment Options Webseminar."}